Korro Bio (KRRO) Cash from Operations (2018 - 2026)
Korro Bio (KRRO) posted Cash from Operations of 16074000.0 for Q1 2026, up 9.2% on a QoQ basis from 17702000.0 in Q4 2025, and up 34.26% year-over-year from 11972020.96 in Q1 2025.
Korro Bio (KRRO) Cash from Operations (2018 - 2026) Analysis & Trends
Korro Bio's Cash from Operations history runs 9 years deep, the most recent figure standing at 16074000.0 for Q1 2026.
- Quarterly Cash from Operations rose 34.26% year-over-year to 16074000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 70183000.0 (down 12.05% YoY) and the FY2025 annual result came in at 78561000.0, down 30.77% from the prior year.
- Cash from Operations was 16074000.0 for Q1 2026 at Korro Bio, up from 17702000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 7495000.0 in Q4 2024 and bottomed at 24452000.0 in Q1 2025.
- A 5-year average of 16213941.18 and a median of 16095000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations surged 64.49% — and 2025, when it plunged 136.18%.
- Korro Bio's Cash from Operations stood at 11027000.0 in 2022, then tumbled by 91.41% to 21107000.0 in 2023, then jumped by 64.49% to 7495000.0 in 2024, then plunged by 136.18% to 17702000.0 in 2025, then grew by 9.2% to 16074000.0 in 2026.
- Business Quant data shows KRRO's Cash from Operations at 16074000.0 in Q1 2026, 17702000.0 in Q4 2025, and 17179000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.07 Mn |
| Mar 31, 2026 | -16.07 Mn |
| Dec 31, 2025 | -17.70 Mn |
| Dec 31, 2025 | -17.70 Mn |
| Sep 30, 2025 | -17.18 Mn |
| Sep 30, 2025 | -17.18 Mn |
| Jun 30, 2025 | -19.23 Mn |
| Jun 30, 2025 | -19.23 Mn |
| Mar 31, 2025 | -24.45 Mn |
| Mar 31, 2025 | -24.45 Mn |
| Dec 31, 2024 | -7.50 Mn |
| Dec 31, 2024 | -7.50 Mn |
| Sep 30, 2024 | -16.10 Mn |
| Sep 30, 2024 | -16.10 Mn |
| Jun 30, 2024 | -14.59 Mn |
| Jun 30, 2024 | -14.59 Mn |
| Mar 31, 2024 | -21.89 Mn |
| Mar 31, 2024 | -21.89 Mn |
| Dec 31, 2023 | -21.11 Mn |
| Dec 31, 2023 | -21.11 Mn |